Related Articles
PI3K inhibition sensitizes EGFR wild‑type NSCLC cell lines to erlotinib chemotherapy
Emodin enhances cisplatin sensitivity in non-small cell lung cancer through Pgp downregulation
Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines
Nimotuzumab enhances the sensitivity of non-small cell lung cancer cells to tumor necrosis factor-α by inhibiting the nuclear factor-кB signaling pathway
Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1 Retraction in /10.3892/or.2022.8461